Hypoxic respiratory failure in term newborns: clinical indicators for inhaled nitric oxide and extracorporeal membrane oxygenation therapy

被引:14
|
作者
Fakioglu, H [1 ]
Totapally, BR [1 ]
Torbati, D [1 ]
Raszynski, A [1 ]
Sussmane, JB [1 ]
Wolfsdorf, J [1 ]
机构
[1] Miami Childrens Hosp, Div Crit Care Med, Miami, FL 33155 USA
关键词
extracorporeal membrane oxygenation; hypoxic respiratory failure; inhaled nitric oxide; persistent pulmonary hypertension of newborn; term newborns;
D O I
10.1016/j.jcrc.2005.05.011
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose: The criteria, for starting extracorporeal membrane oxygenation (ECMO) therapy in term newborn patients with hypoxemic respiratory failure consist of. an oxygenation index (OI) of 25 or higher and alveolar-arterial oxygen (AaO(2)) gradient of more than 600 at sea level. In such. conditions, inhaled. nitric oxide. (iNO) may improve oxygenation and reduce the need for ECMO therapy. We studied early changes in OI and AaO(2) gradients in response to iNO treatment that may indicate a need to continue iNO treatment or the necessity to start an. ECMO therapy. Materials and Methods: In this prospective study, we used 34 outborn neonatal patients that were referred to our pediatric critical care unit in a. children's hospital for ECMO therapy with diagnosis of hypoxemic respiratory failure. In all patients, iNO therapy, starting. at 80 ppm,, was. instituted either during transport or on arrival to hospital. Response, to iNO was assessed after 1 hour, at which time, iNO concentration was reduced to 40 ppm, provided there was more than 20% improvement in either or both oxygenation indices. Patients who,did not respond positively to continuous iNO therapy and met ECMO criteria were given ECMO therapy. Results: Inhaled nitric oxide therapy alone was successful in 10 (29%) of 34 patients. Eighteen patients (53%) required ECMO therapy within the first 10 hours of iNO treatment (early ECMO therapy), whereas. 6 other neonates (18%) became eligible for ECMO therapy after prolonged (2-4 days) iNO treatment (late ECMO therapy). No mortality occurred with. any treatment. Within 4 hours after iNO therapy patients who required early ECMO therapy had significantly higher OI and AaO(2) gradients than patients who were treated with iNO therapy alone. (P <.01, analysis of variance followed by Tukey-Kramer multiple comparison test). Six of 34,patients (18%), categorized as late ECMO therapy, on the average, had initially higher levels of OI and mean airway, pressure than neonates in iNO treatment and early ECMO therapy. Conclusion: Persisting levels of OI of more than 20 or AaO(2) gradients of more than 600 after 4 hours of iNO therapy could be indicative of an immediate need for ECMO therapy. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:288 / 293
页数:6
相关论文
共 50 条
  • [41] Inhaled nitric oxide therapy during the transport of neonates with persistent pulmonary hypertension or severe hypoxic respiratory failure
    Lowe, Calvin G.
    Trautwein, Johnn G.
    EUROPEAN JOURNAL OF PEDIATRICS, 2007, 166 (10) : 1025 - 1031
  • [42] Successful treatment of a patient with multiple injuries using extracorporeal membrane oxygenation and inhaled nitric oxide
    Sasadeusz, KJ
    Long, WB
    Kemalyan, N
    Datena, SJ
    Hill, JG
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2000, 49 (06): : 1126 - 1128
  • [43] Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn
    Hoffman, GM
    Ross, GA
    Day, SE
    Rice, TB
    Nelin, LD
    CRITICAL CARE MEDICINE, 1997, 25 (02) : 352 - 359
  • [44] Evidence-Based Clinical Practice Guideline: Inhaled Nitric Oxide for Neonates With Acute Hypoxic Respiratory Failure
    DiBlasi, Robert M.
    Myers, Timothy R.
    Hess, Dean R.
    RESPIRATORY CARE, 2010, 55 (12) : 1717 - 1745
  • [45] Respiratory management strategy impacts the outcome of hypoxic respiratory failure (HRF) in term and near term infants treated with inhaled nitric oxide (iNO)
    Dudell, GG
    St John, ES
    PEDIATRIC RESEARCH, 2004, 55 (04) : 508A - 508A
  • [46] Inhaled Nitric Oxide in Hypoxic Respiratory Failure in Preterms: Audit of Ten Years of Practice
    Sehgal, A.
    Callander, I
    Stack, J.
    Jain, H.
    Sterling-Levis, K.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2007, 1 (06) : 460 - 466
  • [47] A dose response study of inhaled nitric oxide in hypoxic respiratory failure in preterm infants
    Ahluwalia, J.
    Tooley, J.
    Cheema, I.
    Sweet, D. G.
    Curley, A. E.
    Halliday, H. L.
    Field, D.
    Al'malik, H.
    Annamalai, S.
    Midgley, P.
    Hardy, P.
    Tomlin, K.
    Elbourne, D.
    EARLY HUMAN DEVELOPMENT, 2006, 82 (07) : 477 - 483
  • [48] USE OF EXTRACORPOREAL MEMBRANE-OXYGENATION FOR RESPIRATORY-FAILURE IN TERM INFANTS
    KIRKPATRICK, BV
    KRUMMEL, TM
    MUELLER, DG
    ORMAZABAL, MA
    GREENFIELD, LJ
    SALZBERG, AM
    CRUTE, SL
    PEDIATRICS, 1983, 72 (06) : 872 - 876
  • [49] Inhaled nitric oxide in acute respiratory failure
    Rouby, JJ
    VASCULAR ENDOTHELIUM: RESPONSES TO INJURY, 1996, 281 : 181 - 203
  • [50] Inhaled nitric oxide in acute respiratory failure
    Young, JD
    BRITISH JOURNAL OF ANAESTHESIA, 1997, 79 (06) : 695 - 696